openPR Logo
Press release

Demand For Pharmacogenomic (Pgx) Testing Is Slated To Rise At An 8% CAGR Through 2028

12-09-2022 04:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

Pharmacogenomic (PGx) Testing Market

Pharmacogenomic (PGx) Testing Market

This research report on the worldwide Pharmacogenomic (PGx) Testing market analyses the market conditions and attain prominent aspects such as industry dynamics, key players, product segments, and leading applications. Besides this report presents insights into the global trends in the Pharmacogenomic (PGx) Testing market and recent developments in the market globally. The research is done keeping eye on the revenue potential and Pharmacogenomic (PGx) Testing market share. Apart from the aforementioned factors, this research includes insights into Pharmacogenomic (PGx) Testing market competition. A detailed account of business tactics used by industry players is included in the report.

The research report presents a comprehensive assessment of the Pharmacogenomic (PGx) Testing market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as those on the basis of geographies, applications, and industries.

๐—š๐—ฒ๐˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฆ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=3143

๐—ž๐—ฒ๐˜† ๐—ณ๐—ถ๐—ป๐—ฑ๐—ถ๐—ป๐—ด๐˜€ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐—ด๐—ฒ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ (๐—ฃ๐—š๐˜…) ๐—ง๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐˜€๐˜๐˜‚๐—ฑ๐˜†:

โ€ข The report provides a present market outlook on Low-Calorie Margarine. Additionally, the Low-Calorie Margarine market share is anticipated to grow with a CAGR of 5.5% in the forecast period.
โ€ข Regional breakdown of the Pharmacogenomic (PGx) Testing market based on predefined taxonomy.
โ€ข Innovative manufacturing processes implemented by Pharmacogenomic (PGx) Testing vendors in detail.
โ€ข Region-wise and country-wise fragmentation of the Pharmacogenomic (PGx) Testing market to grasp the revenue, and growth outlook in these areas.
โ€ข Changing preferences among consumers across various regions and countries.
โ€ข Factors (Positive and Negative) impacting the growth of the global Pharmacogenomic (PGx) Testing market.
โ€ข Pharmacogenomic (PGx) Testing price, market share, and Trends forecast for assessment period 2018-2028

๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐—ด๐—ฒ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ (๐—ฃ๐—š๐˜…) ๐—ง๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜: ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป

The global pharmacogenomic (PGx) testing market is segmented based on the by test type, application, end user and region

๐—•๐˜† ๐˜๐—ฒ๐˜€๐˜ ๐˜๐˜†๐—ฝ๐—ฒ ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐—ด๐—ฒ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ (๐—ฃ๐—š๐˜…) ๐˜๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ถ๐˜€ ๐˜€๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฒ๐—ฑ ๐—ฎ๐˜€:
โ€ข Therapeutic Tests
โ€ข Diagnostic Tests

๐—•๐˜† ๐—ฎ๐—ฝ๐—ฝ๐—น๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป, ๐˜๐—ต๐—ฒ ๐—ด๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐—ด๐—ฒ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ (๐—ฃ๐—š๐˜…) ๐˜๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ถ๐˜€ ๐˜€๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฒ๐—ฑ ๐—ฎ๐˜€:
โ€ข Oncology
โ€ข Cardiovascular
โ€ข Others

๐—•๐˜† ๐—ฒ๐—ป๐—ฑ ๐˜‚๐˜€๐—ฒ๐—ฟ, ๐—ด๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐—ด๐—ฒ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ (๐—ฃ๐—š๐˜…) ๐˜๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ถ๐˜€ ๐˜€๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฒ๐—ฑ ๐—ฎ๐˜€:
โ€ข Diagnostic Laboratories
โ€ข Research Laboratories
โ€ข Academic Research Institutes

๐—ง๐—ผ ๐—ฟ๐—ฒ๐—ฐ๐—ฒ๐—ถ๐˜ƒ๐—ฒ ๐—ฒ๐˜…๐˜๐—ฒ๐—ป๐˜€๐—ถ๐˜ƒ๐—ฒ ๐—น๐—ถ๐˜€๐˜ ๐—ผ๐—ณ ๐—ถ๐—บ๐—ฝ๐—ผ๐—ฟ๐˜๐—ฎ๐—ป๐˜ ๐—ฟ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป๐˜€, ๐—ฎ๐˜€๐—ธ ๐—ณ๐—ผ๐—ฟ ๐—ง๐—ข๐—– ๐—ต๐—ฒ๐—ฟ๐—ฒ -https://www.factmr.com/connectus/sample?flag=T&rep_id=3143

๐—ช๐—ต๐—ฎ๐˜ ๐—บ๐—ฎ๐—ธ๐—ฒ๐˜€ ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฑ๐—ถ๐—ณ๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐˜ ๐—ณ๐—ฟ๐—ผ๐—บ ๐—ผ๐˜๐—ต๐—ฒ๐—ฟ๐˜€?

โ€ข COVID- Impact analysis- The report includes details of the impact of the pandemic on the Pharmacogenomic (PGx) Testing market further including insights on the pre-COVID situation. Additionally, this report benefits in terms of post-COVID recovery prospects, changing consumer demands, and buying patterns valuable for Pharmacogenomic (PGx) Testing companies.
โ€ข Industrial trend analysis- The research covers recent trends in the field of Pharmacogenomic (PGx) Testing which are augmented with the applicable technologies and shifts in industrial processes. The scope for digital and industrial technologies is discussed in order to help client firms to understand the benefits and risks included in light of market trends.
โ€ข Pharmacogenomic (PGx) Testing Sustainability metrics- The rising concerns of environmentally friendly production and consumption are taken to next level in this research, as research is focused on emerging methods of ensuring sustainability. These insights include climate-friendly initiatives adopted by some players in the industry. Furthermore, details of manufacturers' impact on carbon footprint are evaluated intend to make clients aware of their contribution to sustainable development goals.

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ

The Pharmacogenomic (PGx) Testing industry is dominated by some prominent players including
Affymetrix, Inc., Becton Dickinson and Company, Bayer AG, Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., AstraZeneca PLC, QIAGEN and others
The competition in the sector is driven by key parameters such as product price, targeted customer base, and strategic marketing. Major players in the market focused on the Pharmacogenomic (PGx) Testing market innovation by investing more in research and development. Furthermore, the industry players are focusing on the extensive usage of online distribution channels for enhanced cost-effectiveness. The sustainability in the supply chain is a decisive factor for Pharmacogenomic (PGx) Testing brands leading to an impact on the margin profits of firms.

๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—•๐—ฒ๐—ป๐—ฒ๐—ณ๐—ถ๐˜๐˜€ & ๐—ž๐—ฒ๐˜† ๐—ค๐˜‚๐—ฒ๐˜€๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—”๐—ป๐˜€๐˜„๐—ฒ๐—ฟ๐—ฒ๐—ฑ

โ€ข Pharmacogenomic (PGx) Testing Company & brand share analysis: Company and brand share analysis on Pharmacogenomic (PGx) Testing reveals how much market share is captured by Tier 1, Tier 2, and Tier 3 players
โ€ข Pharmacogenomic (PGx) Testing Historical volume analysis: The industry analysis provides data & insights on historical volume sales of Pharmacogenomic (PGx) Testing
โ€ข Pharmacogenomic (PGx) Testing Category & segment level analysis: Fact.MR's Pharmacogenomic (PGx) Testing sales outlook offers category and segment level analysis on lucrative and nascent product types. Market players can use this information to identify sales potential and set sales targets at local, country, and regional level.
โ€ข Pharmacogenomic (PGx) Testing Consumption by demographics: The market intelligence study provides consumption by demographics analysis so market players can design their product and marketing strategies on the basis of high-value consumers
โ€ข Post COVID consumer spending on Pharmacogenomic (PGx) Testing: The report includes post COVID consumer spending analysis. This information will help business leads understand the shifts in purchasing power and behavior
โ€ข Manufacturing trend analysis: Vital information on how market players are aligning their manufacturing strategies with respect to evolving consumer sentiments

๐—™๐—ผ๐—ฟ ๐—ถ๐—ป-๐—ฑ๐—ฒ๐—ฝ๐˜๐—ต ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ฎ๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€, ๐—•๐˜‚๐˜† ๐—ก๐—ผ๐˜„ -https://www.factmr.com/checkout/3143

๐—ช๐—ต๐˜† ๐—ฐ๐—ต๐—ผ๐—ผ๐˜€๐—ฒ ๐—™๐—ฎ๐—ฐ๐˜.๐— ๐—ฅ?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients' requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

๐—™๐—ผ๐—ฟ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€:
https://www.prnewswire.com/news-releases/how-bobcat-emea-region-boosted-up-their-skid-steer-loader-sales-by-12-7-factmr-301217359.html

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

About Us:
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Demand For Pharmacogenomic (Pgx) Testing Is Slated To Rise At An 8% CAGR Through 2028 here

News-ID: 2842941 • Views: โ€ฆ

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA โ€ฆ
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % betweenโ€ฆ
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; โ€ฆ
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand forโ€ฆ
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva โ€ฆ
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Keyโ€ฆ
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico โ€ฆ
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rateโ€ฆ

All 5 Releases


More Releases for PGx

Global Pharmacogenomics (PGx) Market Expected to Witness a Sustainable Growth ov โ€ฆ
The latest research report"Global Pharmacogenomics (PGx) Market Growth 2025-2031" studied by LP Information offers a comprehensive overview of thePharmacogenomics (PGx) market, providing insights into its drivers, restraints, and future trends. This study utilizes a comprehensive and thorough research methodology to provide an objective perspective on the global Pharmacogenomics (PGx) industry, helping decision-makers make informed business decisions. According to the report "Global Pharmacogenomics (PGx) Market Growth Trends 2025-2031" published by LP Information,โ€ฆ
Pharmacogenomics (PGX) Market Key Innovations 2025-2032
The Pharmacogenomics (PGX) market is at the forefront of a transformative wave in personalized medicine, revolutionizing how healthcare professionals approach treatment plans based on individual genetic profiles. PGX merges pharmacology and genomics to tailor drug therapies, enhancing efficacy and minimizing adverse effects. As the healthcare landscape evolves, the demand for PGX solutions is surging, driven by a growing emphasis on precision medicine, which seeks to optimize therapeutic outcomes for patients. Recentโ€ฆ
Pharmacogenomics (PGx) Market Size, Trends 2031 By Key Players- Abbott Laborator โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ: According to Verified Market Reports analysis, the global Pharmacogenomics (PGx) Market size was valued at USD 16.5 Billion in 2023 and is projected to reach USD 32.1 Billion By 2031, growing at a CAGR of 9.17% during the forecast period 2024 to 2031. The Pharmacogenomics (PGx) Market presents significant opportunities for growth driven by the increasing demand for personalized medicine and advancements in genomic technologies. Pharmacogenomics, which studiesโ€ฆ
Pharmacogenomics (PGx) Market Skyrocketing Revenue Growth of USD 11.63 Billion, โ€ฆ
The global Pharmacogenomics (PGx) Market is expected to grow from USD 6.73 billion in 2020 to USD 11.63 billion by 2030, at a CAGR of +7% during the forecast period 2022-2030. Pharmacogenomics (PGx), is the study of how people respond differently to drug therapy based upon their genetic makeup. Pharmacogenomics is part of the field of precision medicine, which aims to treat each patient individually. It uses genomic information to studyโ€ฆ
Pharmacogenomics (PGx) Market with High Grow in CAGR of +8% with Prominent Key P โ€ฆ
According to The Global Market Vision, the Latest research report on "Pharmacogenomics (PGx) Market size accounted for $5,312.8 million in 2022 and is projected to reach $10,265.5 million by 2030, registering a CAGR of +8% from 2022 to 2030. The increase in the elderly population, the surge in the adoption of pharmacogenomics procedures by healthcare professionals, growing awareness of the patient population towards personalized therapy, and growth in prevalence of chronicโ€ฆ
Global Pharmacogenomics (PGx) Market 2022 Key Indicators - Abbott Laboratories, โ€ฆ
The market study based on the Global Pharmacogenomics (PGx) Market published byย The Brainy Insightsย provides an up-to-date and accurate market picture. It also provides important data on the various components which affect the progress of the Pharmacogenomics (PGx) market through a brief scan and detailed information. The report will help stakeholders and partners define the best development methods and take advantage of the opportunities prevailing in the Pharmacogenomics (PGx) market. Aโ€ฆ